Once the dust finally settles from the COVID-19 crisis, the last thing issuers will want is to face an inquiry and possible enforcement action by the SEC.
“Disney has gone from being on top of the world a la Lion King, to feeling like Eeyore stuck in the middle of a perfect storm with no end in sight."
Now is not the time to eliminate important investor information. It is a time to enhance and improve some of the key sections of registrant filings.
The commission has halted trading in the shares of three companies that have said they are developing a drug candidate for treating COVID-19.
The company expects coronavirus-related disruptions will “increase our operating costs and negatively impact our volumes" for the rest of this year.
The key to survival in a recession is to anticipate a lender’s every move and every question.
“COVID-19 has significantly impacted near-term demand, resulting in oversupplied markets and unprecedented pressure on commodity prices and margins."
The company expects to plow its entire Q2 operating profit back into "getting products to customers and keeping employees safe.”
The new program widens the pool of applicants and adds loan types.
Use these three insights to improve remote work in the wake of the pandemic.
“During the first quarter, both diagnostics and drug development began experiencing the impact of the global pandemic," CEO Adam Schecter says.
The health-care company allegedly made bogus claims it had created a “direct pipeline from manufacturers and suppliers to buyers” of N95 masks.
